The HTLV-1 neurological complex

被引：151

作者：

Araujo, Abelardo Q. C.

Silva, Marcus Tulius T.

机构：

[1] Fiocruz MS, IPEC, Reference Ctr Neurol, BR-21045900 Rio De Janeiro, Brazil

[2] Fiocruz MS, IPEC, Ref Ctr HTLV, BR-21045900 Rio De Janeiro, Brazil

[3] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil

来源：

LANCET NEUROLOGY | 2006年 / 5卷 / 12期

关键词：

D O I：

10.1016/S1474-4422(06)70628-7

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million people worldwide and causes immune-mediated diseases of the nervous system. The classic neurological presentation of HTLV-1 infection is a myelopathy called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, HAM/TSP is not the only neurological outcome that can result from HTLV-1 infection. In this Personal View, we show that HTLV-1 has a broader neurological spectrum than the names HAM/TSP suggest and that people infected with this virus can present with various isolated or assorted syndromes.

引用

收藏

页码：1068 / 1076

页数：9

相关论文

共 82 条

[71] ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING HTLV-I ASSOCIATED MYELOPATHY [J].

TACHI, N ;

WATANABE, T ;

WAKAI, S ;

SATO, T ;

CHIBA, S .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 110 (1-2) :234-235

[72] Immunopathogensis of HTLV-I associated neurologic disease: Molecular, histopathologic, and immunologic approaches [J].

Takenouchi, N ;

Yao, K ;

Jacobson, S .

FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :2527-2539

[73] Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis [J].

Takenouchi, N ;

Yamano, Y ;

Usuku, K ;

Osame, M ;

Izumo, S .

JOURNAL OF NEUROVIROLOGY, 2003, 9 (01) :29-35

[74]

TAMIYA S, 1995, LEUKEMIA, V9, P1768

[75]

Tateyama M, 1999, No To Shinkei, V51, P723

[76] Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy [J].

Taylor, GP ;

Hall, SE ;

Navarrete, S ;

Michie, CA ;

Davis, R ;

Witkover, AD ;

Rossor, M ;

Nowak, MA ;

Rudge, P ;

Matutes, E ;

Bangham, CRM ;

Weber, JN .

JOURNAL OF VIROLOGY, 1999, 73 (12) :10289-10295

[77] IMMUNOCYTOCHEMICAL ANALYSIS OF THE CELLULAR INFILTRATE IN THE SPINAL-CORD LESIONS IN HTLV-I-ASSOCIATED MYELOPATHY [J].

UMEHARA, F ;

IZUMO, S ;

NAKAGAWA, M ;

RONQUILLO, AT ;

TAKAHASHI, K ;

MATSUMURO, K ;

SATO, E ;

OSAME, M .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (04) :424-430

[78] Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis [J].

Vine, AM ;

Witkover, AD ;

Lloyd, AL ;

Jeffery, KJM ;

Siddiqui, A ;

Marshall, SEF ;

Bunce, M ;

Eiraku, N ;

Izumo, S ;

Usuku, K ;

Osame, M ;

Bangham, CRM .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (07) :932-939

[79]

Watanabe T, 1997, INT J HEMATOL, V66, P257

[80]

Watanabe Toshiki, 1997, Leukemia (Basingstoke), V11, P582

← 1 2 3 4 5 6 7 8 9 →